CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Almotriptan

Last Updated: December 24, 2003
Result type: Reports
Project Number: S0005
Product Line: Common Drug Review

Generic Name: Almotriptan

Brand Name: Axert

Manufacturer: Janssen-Ortho Inc.

Indications: Migraine

Submission Type: New

Project Status: Complete

Date Recommendation Issued: May 27, 2004

Recommendation Type: List in a similar manner to other drugs in class